La Opinión strikes deal with Eli Lilly

La Opinión (Impremedia, daily, circ. 125,000, Spanish) signed a deal with Eli Lilly to publish an 8 to12 page mental health supplement which will be distributed as an insert inside La Opinión.

The partnership with Eli Lilly could be expanded to include similar inserts in Impremedia's two other publications – La Raza in Chicago and el diario/La Prensa in New York. Impremedia wants to expands the programm to other pharmaceutical companies. Other sponsors for pharma-focused publications include Roche, Novartis and Pfizer.